Dr. Feld graduated from medical school at the University of Toronto in 1997 and then completed residency programs in Internal Medicine and Gastroenterology. Following his clinical training, Dr. Feld focused on developing skills in clinical and laboratory research in liver disease, with a particular interest in viral hepatitis. He completed a clinical research fellowship in hepatology and then spent 4 years doing clinical and laboratory research in the Liver Diseases Branch of the National Institutes of Health. He received a Masters of Public Health with a focus on Infectious Diseases as a Sommer Scholar from Johns Hopkins University and has worked extensively abroad, maintaining a strong interest in International Health. Curently, Dr. Feld is clinician-scientist based at the Toronto Western Hospital Liver Clinic and the McLaughlin-Rotman Centre for Global Health.
Dr. Felds research focuses on understanding treatment non-response in hepatitis C and more broadly on understanding the antiviral immune response and developing new strategies for the treatment of viral hepatitis.
Expert Rev Mol Diagn. 2017 Nov 01;:
Hepatology. 2017 Sep 06;:
Risk for hepatocellular carcinoma after HCV antiviral therapy with direct-acting antivirals: case closed?
Gastroenterology. 2017 Aug 31;:
Author response to Letters to the Editor LIVint-17-00581 "Cytoplasmic rods and rings in ribavirin treatment" Covini et al and LIVint-17-00867 "Cytoplasmic rods and rings in mycophenolic acid treatment" Chen et al.
Liver Int. 2017 Aug 29;:
CMAJ Open. 2017 Aug 25;5(3):E662-E672
Toronto HCC Risk Index: A validated scoring system to predict 10-year risk of HCC in patients with cirrhosis.
J Hepatol. 2017 Aug 24;:
HBV screening before adjuvant chemotherapy in patients with early breast cancer: A cost-effectiveness analysis.
J Clin Oncol. 2014 Oct 20;32(30_suppl):11
J Clin Oncol. 2014 Oct 20;32(30_suppl):169
J Clin Oncol. 2013 Nov;31(31_suppl):228
Wait Time for Curative Intent Radio Frequency Ablation is Associated with Increased Mortality in Patients with Early Stage Hepatocellular Carcinoma.
Ann Hepatol. 2017 Aug 08;16(5):765-771
Scientist, Toronto General Hospital Research Institute (TGHRI)
Scientist, Sandra Rotman Centre for Global Health, Toronto, Ontario, Canada
Research Director, Gastroenterology, Medicine/University of Toronto, Francis Family Liver Clinic - Toronto Western Hospital, Toronto, Ontario, Canada
Associate Professor of Medicine, University of Toronto, Toronto, Ontario, Canada